2021
DOI: 10.1016/j.fertnstert.2021.04.017
|View full text |Cite
|
Sign up to set email alerts
|

Human embryo genetic editing: hope or pipe dream?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 3 publications
(2 reference statements)
0
1
0
Order By: Relevance
“…Genome editing has been used to correct gene mutations in mice and mimic human genetic diseases, [529][530][531][532][533] and correct pathogenic gene mutations in human embryos. 534,535 CRISPR-edited T cells in patients with cancers have been tested in clinical trials. [536][537][538] Genome editing technology in the targeted therapy has shown a promising prospect for human diseases, 539,540 especially, in fertility restoration in cancer survivors and prevention of paternal transmission of diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Genome editing has been used to correct gene mutations in mice and mimic human genetic diseases, [529][530][531][532][533] and correct pathogenic gene mutations in human embryos. 534,535 CRISPR-edited T cells in patients with cancers have been tested in clinical trials. [536][537][538] Genome editing technology in the targeted therapy has shown a promising prospect for human diseases, 539,540 especially, in fertility restoration in cancer survivors and prevention of paternal transmission of diseases.…”
Section: Discussionmentioning
confidence: 99%